Sep 12, 2023 / 12:30PM GMT
Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
All right. Thank you. Good morning. Why don't we get started? My name is Jeff Johnson. I'm the senior medical technology analyst at Baird, and our first presentation this morning is from Enovis Corporation, a leader in the $4 billion Prevention & Recovery markets and in the $38 billion global orthopedic implant market.
With us today from Enovis, we're happy to have CEO, Matt Trerotola; Chief Financial Officer, Ben Berry. And Matt, I'm going to turn it over to you, if you have a few minutes of prepared remarks, and then we'll go straight into Q&A. Thanks.
Matthew L. Trerotola - Enovis Corporation - CEO & Chairman
Yes, sounds good. Thanks. Thanks a lot, Jeff. Hey, everybody. Great to see you. Thanks for being here and for tuning in. Glad to have an opportunity to share a little bit about our company.
I'll start with forward-looking statements comments here. And to introduce our company, we are a MedTech growth company, Enovis.
Enovis Corp at Robert W Baird Global Healthcare Conference Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers